Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
Chauvin, Manon (Sorbonne Université)
Larsen, Martin (Sorbonne Université)
Quirant, Bibiana (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Quentric, Paul (Sorbonne Université)
Dorgham, Karim (Sorbonne Université)
Royer, Luca (Sorbonne Université)
Vallet, Hélène (Assistance Publique-Hôpitaux de Paris)
Guihot, Amelie (Assistance Publique-Hôpitaux de Paris)
Combadiere, Behazine (Sorbonne Université)
Combadière, Christophe (Sorbonne Université)
Barallat, Jaume (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Mayaux, Julien (Assistance Publique-Hôpitaux de Paris)
Luyt, Charles-Edouard (Assistance Publique-Hôpitaux de Paris)
Mathian, Alexis (Assistance Publique Hôpitaux de Paris)
Amoura, Zahir (SAssistance Publique Hôpitaux de Paris)
Boddaert, Jacques (Assistance Publique-Hôpitaux de Paris)
Arméstar, Fernando (Universitat Autònoma de Barcelona. Departament de Medicina)
Gorochov, Guy (Assistance Publique-Hôpitaux de Paris (AP-HP))
Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Sauce, Delphine (Sorbonne Université)
Data: |
2021 |
Resum: |
Innate immune activation during Covid-19 infection is associated with pernicious clinical outcome. Coronavirus disease 2019 (Covid-19) is a worldwide threat that has already caused more than 3 000 000 deaths. It is characterized by different patterns of disease evolution depending on host factors among which old-age and pre-existing comorbidities play a detrimental role. Previous coronavirus epidemics, notably SARS-CoV, were associated with increased serum neopterin levels, which can be interpreted as a sign of acute innate immunity in response to viral infection. Here we hypothesize that neopterin may serve as a biomarker of SARS-CoV-2 viral infection and Covid-19 disease severity. We measured neopterin blood levels by ELISA. Seric concentration was quantified from 256 healthy donors and 374 Covid-19 patients at hospital admission. Enrolled Covid-19 patients were all symptomatic and displayed a large spectrum of comorbidities. Patients were followed until disease resolution or death. Severe and critically ill SARS-CoV-2 infected patients were characterized by a profound exacerbation of immune activation characterized by elevated neopterin blood levels. Systemic neopterin levels above 19nM stratified healthy individuals from Covid-19 patients with 87% specificity and 100% sensitivity. Moreover, systemic neopterin levels above 53nM differentiated non-survivors from survivors with 64% specificity and 100% sensitivity. We propose that neopterin concentration measured at arrival to hospital is a hallmark of severe Covid-19 and identifies a high-risk population of pernicious clinical outcome with a need for special medical care. |
Drets: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Llengua: |
Anglès |
Document: |
Article ; recerca ; Versió publicada |
Matèria: |
SARS-CoV-2 ;
Biomarker ;
Neopterin ;
Clinical outcome ;
Death |
Publicat a: |
Frontiers in cellular and infection microbiology, Vol. 11 (August 2021) , art. 709893, ISSN 2235-2988 |
DOI: 10.3389/fcimb.2021.709893
PMID: 34497777
El registre apareix a les col·leccions:
Documents de recerca >
Documents dels grups de recerca de la UAB >
Centres i grups de recerca (producció científica) >
Ciències de la salut i biociències >
Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)Articles >
Articles de recercaArticles >
Articles publicats
Registre creat el 2021-09-13, darrera modificació el 2023-10-01